Profluent is seeking a rigorous and highly collaborative Associate Director - Director to lead in vivo pharmacology strategy and execution for their customized base editor therapeutics. This role will oversee rodent and non-human primate (NHP) studies designed to evaluate editing activity, delivery, biodistribution, durability, tolerability, biomarker response, and translational potential. The successful candidate will serve as the in vivo pharmacology lead on cross-functional program teams, partnering closely with gene editing, protein engineering, delivery, computational biology, bioanalytics, translational science, and external CROs. This role will generate and interpret decision-quality in vivo datasets that guide editor selection, dose strategy, candidate nomination, and IND-enabling development plans. This is an excellent opportunity to help build the in vivo pharmacology function for a new class of AI-designed gene editing medicines and to shape how Profluent advances therapeutic candidates from discovery into development.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree